# Cellulitis Optimal Antibiotic Treatment

> **NCT05584007** · PHASE3 · RECRUITING · sponsor: **University of Southampton** · enrollment: 334 (estimated)

## Conditions studied

- Cellulitis of Leg

## Interventions

- **DRUG:** Flucloxacillin Only Product in Oral Dose Form
- **DRUG:** Placebo Only Product in Oral Dose Form

## Key facts

- **NCT ID:** NCT05584007
- **Lead sponsor:** University of Southampton
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-29
- **Primary completion:** 2026-05
- **Final completion:** 2027-07
- **Target enrollment:** 334 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584007, "Cellulitis Optimal Antibiotic Treatment". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT05584007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*